Tissue Engineering & Microfluidics Laboratory, Australian Institute for Bioengineering & Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia.
Regen Med. 2011 Mar;6(2):167-70. doi: 10.2217/rme.11.7.
The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focused on the vascularization of tissue engineering constructs, an issue that is critical for the success of larger tissue engineered constructs and was central to the meeting overall. In addition, a wide range of research also presented developments in tissue engineering for a range of body tissues (including cardiac, neural, bone, cartilage, tendon, skeletal muscle and skin), as well as advances in technologies (high-throughput screening and microfluidics). Looking more broadly, the meeting incorporated developments covering the spectrum of fundamental research through to clinical studies, with discussions on how best to direct the scientific advances being made into realistic therapies that could be made widely available in the future. Overall, the meeting highlighted the promise of early strategies, which are now showing promising results in clinical trials, and the development of a strong foundation of research from which future therapies will no doubt be developed.
组织工程与再生医学国际学会-亚太分会（TERMIS-AP）于 2010 年 9 月 15 日至 17 日在澳大利亚悉尼举行，重点介绍了亚太地区组织工程和再生医学的最新发展。几个全体会议的主题集中在组织工程构建物的血管化，这是大型组织工程构建物成功的关键，也是整个会议的核心。此外，广泛的研究还展示了一系列身体组织（包括心脏、神经、骨骼、软骨、肌腱、骨骼肌和皮肤）的组织工程进展，以及技术（高通量筛选和微流控）的进展。更广泛地说，会议涵盖了从基础研究到临床研究的各个方面的发展，讨论了如何将取得的科学进展最好地转化为现实的治疗方法，以便在未来广泛应用。总的来说，会议强调了早期策略的前景，这些策略现在在临床试验中显示出了有希望的结果，并且为未来的治疗方法奠定了坚实的研究基础。
